Feb 13
|
10 Dermatologists Driving Growth for Skin Care Brands on TikTok
|
Feb 9
|
Roche cutting jobs in product development - media
|
Jan 12
|
The Zacks Analyst Blog Highlights Roche, Netflix, NIKE, Uber, Technologies and Prologis
|
Jan 12
|
Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space
|
Jan 11
|
Top Research Reports for Roche, Netflix & NIKE
|
Jan 11
|
Renewables grew rapidly in 2023, but must grow faster still to meet climate change target, IEA says
|
Jan 10
|
JPM's annual healthcare conference: Here's what's next for GLP-1s and the weight loss market
|
Jan 10
|
Why Sarepta's (SRPT) Stock Price Moved Up 17% on Tuesday
|
Jan 10
|
Swiss Pharma Giants Who Missed Boat on Obesity Fight to Stay Relevant
|
Jan 9
|
How Roche aims to change the 'standard of care'
|
Jan 9
|
Sarepta (SRPT) Rises on Solid Q4 and 2023 Preliminary Results
|
Jan 9
|
Should You Invest in Roche Holding AG (RHHBY)?
|
Jan 3
|
Remix Therapeutics Enters Collaboration with Roche for the Discovery and Development of Small Molecule Therapeutics Modulating RNA Processing
|
Jan 3
|
Roche joins startup Remix in bet on another way to drug RNA
|
Jan 2
|
Roche to buy LumiraDx’s point-of-care technology for $295M
|
Jan 2
|
Roche (RHHBY) to Acquire LumiraDx's Point of Care Technology
|
Dec 29
|
Roche to buy part of LumiraDx diagnostics platform for $295 million
|
Dec 29
|
Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform
|
Dec 26
|
Sarepta (SRPT) Seeks Label Expansion for DMD Gene Therapy
|
Dec 21
|
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
|